Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
D000172:Acromegaly / Q000097:blood / Q000188:drug therapy*; D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D013006:Growth Hormone / Q000037:antagonists & inhibitors / Q000097:blood*; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D006207:Half-Life; D006801:Humans; D007328:Insulin / Q000097:blood*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood; D013997:Time Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D010455:Peptides; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone